ZA865235B - Immunogenic peptide antigen corresponding to pasmodium vivax circumsporozolte protein - Google Patents

Immunogenic peptide antigen corresponding to pasmodium vivax circumsporozolte protein

Info

Publication number
ZA865235B
ZA865235B ZA865235A ZA865235A ZA865235B ZA 865235 B ZA865235 B ZA 865235B ZA 865235 A ZA865235 A ZA 865235A ZA 865235 A ZA865235 A ZA 865235A ZA 865235 B ZA865235 B ZA 865235B
Authority
ZA
South Africa
Prior art keywords
pct
protein
pasmodium
circumsporozolte
vivax
Prior art date
Application number
ZA865235A
Other languages
English (en)
Inventor
David E Arnot
Vicenzo Enea
Ruth S Nussenzweig
Victor N Nussenzweig
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of ZA865235B publication Critical patent/ZA865235B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA865235A 1985-07-12 1986-09-03 Immunogenic peptide antigen corresponding to pasmodium vivax circumsporozolte protein ZA865235B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75464585A 1985-07-09 1985-07-09

Publications (1)

Publication Number Publication Date
ZA865235B true ZA865235B (en) 1987-03-25

Family

ID=25035714

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA865235A ZA865235B (en) 1985-07-12 1986-09-03 Immunogenic peptide antigen corresponding to pasmodium vivax circumsporozolte protein

Country Status (13)

Country Link
US (1) US5700906A (pt)
EP (1) EP0229829B1 (pt)
JP (1) JPS63500591A (pt)
AT (1) ATE118784T1 (pt)
AU (1) AU590599B2 (pt)
DE (1) DE3650242T2 (pt)
DK (1) DK124087A (pt)
ES (2) ES2002467A6 (pt)
IL (1) IL79277A0 (pt)
NZ (1) NZ216823A (pt)
PT (1) PT82975B (pt)
WO (1) WO1987000533A1 (pt)
ZA (1) ZA865235B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
IT1226711B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Antigeni sintetici utili per la diagnosi della malaria da plasmodium vivax.
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
SE8904100D0 (sv) * 1989-12-05 1989-12-05 Astra Ab New analysis method
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
AU5649290A (en) * 1989-04-12 1990-11-05 New York University Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
ES2202218T3 (es) * 1999-12-17 2004-04-01 Schott Glas Capsula fulminante activable inductivamente para sistemas de retencion de pasajeros y circuito de prueba para esta capsula fulminante.
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
US20040176283A1 (en) * 2002-04-01 2004-09-09 Robinson John A. Methods and compositions for the design of synthetic vaccines
WO2004089407A2 (en) * 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
TWI380996B (zh) 2004-09-17 2013-01-01 Hoffmann La Roche 抗ｏｘ４０ｌ抗體
US7749519B2 (en) * 2005-12-09 2010-07-06 Kim Lee Sim Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
AU2007276217B2 (en) * 2006-07-18 2013-08-29 Glaxosmithkline Biologicals S.A. Vaccines for malaria
WO2013009945A1 (en) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Lipid-containing psa compositions, methods of isolation and methods of use thereof
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US20140272993A1 (en) * 2013-03-15 2014-09-18 The Translational Genomics Research Institute Method of sequencing a full microrna profile from cerebrospinal fluid
CN108135167B (zh) 2015-08-19 2021-07-09 哈佛学院院长及董事 脂化psa组合物和方法
WO2018014012A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4559602A (en) * 1983-01-27 1985-12-17 Bates Jr John K Signal processing and synthesizing method and apparatus
US4769235A (en) * 1984-01-27 1988-09-06 New York University Immunodominant epitope of the circumsporozoite surface protein
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
NZ213303A (en) * 1984-09-12 1988-09-29 Univ New York Plasmodium protein, dna sequence and vaccine
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene

Also Published As

Publication number Publication date
DE3650242D1 (de) 1995-03-30
DE3650242T2 (de) 1995-06-14
WO1987000533A1 (en) 1987-01-29
ES2006631A6 (es) 1989-05-01
DK124087D0 (da) 1987-03-11
DK124087A (da) 1987-03-11
AU590599B2 (en) 1989-11-09
EP0229829A4 (en) 1988-07-27
EP0229829A1 (en) 1987-07-29
NZ216823A (en) 1990-12-21
JPS63500591A (ja) 1988-03-03
PT82975A (en) 1986-08-01
ES2002467A6 (es) 1988-08-16
IL79277A0 (en) 1986-09-30
PT82975B (pt) 1988-07-01
EP0229829B1 (en) 1995-02-22
ATE118784T1 (de) 1995-03-15
US5700906A (en) 1997-12-23
AU6129286A (en) 1987-02-10

Similar Documents

Publication Publication Date Title
ZA865235B (en) Immunogenic peptide antigen corresponding to pasmodium vivax circumsporozolte protein
PT77515A (en) Immunogenic protein or peptide complex method of producing said complex and use thereof as an immune stimulant and as a vaccine
GB2143830A (en) Expression of plasmodium falciparum polypeptides from cloned cdna
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
ZA851305B (en) Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum
ES8800273A1 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
NZ234049A (en) Peptide epitopes of, and antibodies to htlv-1
ATE81136T1 (de) Immunogenes produkt, erhalten durch expression in einer rekombinanten hefe, und verfahren zu seiner reinigung.
IL108419A0 (en) Proteinaceous extract derived from eimeria maxima gametocytes and vaccines against eimeria maxima containing the same
ATE159172T1 (de) Peptide und deren verwendung
ES2006730A6 (es) Un metodo de preparar un peptido o polipeptido sintetico que presenta la antigenicidad de la totalidad o una parte de un antigeno de p. falciparum
MY102593A (en) Antigents of plasmodium falciparum
AR241963A1 (es) Reactivo para la determinacion de anticuerpos antiesporozoito de p. falciparum en muestras de sangre humana y o sus derivados, procedimiento para la preparacion de dicho reactivo.
ES2009587A6 (es) Un metodo para purificar un polipeptido.
MY104081A (en) Rhoptry membrane antigen of plasmodium falciparum.
IL94063A0 (en) Plasmodium circumsporozoite protein analogs lacking repeat sequences and their expression by recombinant methods
EP0217877A4 (en) VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
AU7163091A (en) Novel malarial sporozoite peptide antigens
AU2384688A (en) Monoclonal antibodies to a plasmodium falciparum protein
AU6687786A (en) Asexual blood stage antigens of plasmodium falciparum
AU2609588A (en) Rhoptry antigen of plasmodium falciparum
EP0320034A3 (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
IE861786L (en) Immunogenic peptide antigen corresponding to plasmodium¹vivaz circumsporozoite protein
CS33589A1 (en) Peptides with properties of hpv-virus protein's antigen determinant and method of their production
AU7632191A (en) Asexual blood stage antigens of plasmodium falciparum